Professor and Vice Chair for Research, Orthopaedic Surgery, University of Virginia School of Medicine
Orthopaedic Surgery
Dr. Quanjun Cui, MD
|
|
Give Review
Doctor Quanjun Cui, MD is an expert in the field of Orthopaedic Surgery. He received awards:"CMS Meaningful Use Stage 1 Certification". Quanjun Cui is a published MD. He has 50 publications published. The most current publication "Poly(lactic-co-glycolide) polymer constructs cross-linked with human BMP-6 and VEGF protein significantly enhance rat mandible defect repair." Quanjun Cui accepts Medicare.
Publications
- Current concepts of bone tissue engineering for craniofacial bone defect repair.
- Cross-Talk Between VEGF and BMP-6 Pathways Accelerates Osteogenic Differentiation of Human Adipose-Derived Stem Cells.
- Does osteonecrosis of the femoral head increase surgical and medical complication rates after total hip arthroplasty? A comprehensive analysis in the United States.
- Expression of CD105 and CD34 receptors controls BMP-induced in vitro mineralization of mADSCs but does not predict their in vivo bone-forming potential.
- Lyn Regulates Cytotoxicity in Respiratory Epithelial Cells Challenged by Cigarette Smoke Extracts.
- Intraoperative fat embolism during core decompression and bone grafting for osteonecrosis of the hip: report of 3 cases and literature review.
- The applications of buckminsterfullerene C60 and derivatives in orthopaedic research.
- Cement Spacers in Periprosthetic Joint Infection.
- Adenoviral Delivery of the VEGF and BMP-6 Genes to Rat Mesenchymal Stem Cells Potentiates Osteogenesis.
- Combined angiogenic and osteogenic factor delivery for bone regenerative engineering.
- Reducing Costly Falls of Total Knee Replacement Patients.
- The pathogenesis of nontraumatic osteonecrosis.
- Current concepts in management of femoroacetabular impingement.
- Osteogenic response of human adipose-derived stem cells to BMP-6, VEGF, and combined VEGF plus BMP-6 in vitro.
- Interferon gamma and T cells inhibit osteogenesis induced by allogeneic mesenchymal stromal cells.
- Fullerol antagonizes dexamethasone-induced oxidative stress and adipogenesis while enhancing osteogenesis in a cloned bone marrow mesenchymal stem cell.
- Osteonecrosis of the femoral head: An update in year 2012.
- Total hip arthroplasty in developmental dysplasia of the hip: Review of anatomy, techniques and outcomes.
- Local delivery of FTY720 accelerates cranial allograft incorporation and bone formation.
- Emerging ideas: treatment of precollapse osteonecrosis using stem cells and growth factors.
- Combined VEGF and LMP-1 delivery enhances osteoprogenitor cell differentiation and ectopic bone formation.
- Peptides from phage display library modulate gene expression in mesenchymal cells and potentiate osteogenesis in unicortical bone defects.
- VEGF and BMP-6 enhance bone formation mediated by cloned mouse osteoprogenitor cells.
- Distal femoral fractures: current concepts.
- Blood supply to the chicken femoral head.
- The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720.
- Impingement-free hip motion: the 'normal' angle alpha after osteochondroplasty.
- Lipofibromatous hamartoma of a digital nerve.
- Mandated venous thromboembolism prophylaxis: possible adverse outcomes.
- Diagnosis and treatment of the infected primary total knee arthroplasty.
- Surgical and molecular advances in osteonecrosis: editorial comment.
- Preventive effects of puerarin on alcohol-induced osteonecrosis.
- Acute sciatic neuritis following total hip arthroplasty: a case report.
- Treatment options and allograft use in revision total hip arthroplasty the acetabulum.
- Adverse effects of increased body mass index and weight on survivorship of total knee arthroplasty and subsequent outcomes of revision TKA.
- Late presentation of a mycotic popliteal artery pseudoaneurysm in the setting of a revised total knee arthroplasty complicated by both prior infection and periprosthet...
- Advances in hip arthroplasty in the treatment of osteonecrosis.
- Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty.
- Use of genetically engineered bone-marrow stem cells to treat femoral defects: an experimental study.
- Outcomes of total and unicompartmental knee arthroplasty for secondary and spontaneous osteonecrosis of the knee.
- Alcohol-induced adipogenesis in a cloned bone-marrow stem cell.
- Patellofemoral instability after total knee arthroplasty.
- Treatment of posttraumatic adhesive capsulitis of the ankle: a case series.
- Steroid effects on osteogenesis through mesenchymal cell gene expression.
- Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cel...
- Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis.
- Antioxidative fullerol promotes osteogenesis of human adipose-derived stem cells.
- Fullerene-biomolecule conjugates and their biomedicinal applications.
- Poly(lactic-co-glycolide) polymer constructs cross-linked with human BMP-6 and VEGF protein significantly enhance rat mandible defect repair.
Schools
Henan Medical University
University Of Virginia School Of Med
Procedures Preformed
- Excision of Femur or Knee
- Excision of Tibula or Fibula
- Foot and Ankle Fracture Treatment, Open
- Hip Fracture and-or Dislocation Treatment, Closed
- View All
Doctors Specialties
- Orthopedic Hip Surgery
- Orthopedic Knee Surgery
- Orthopedic Surgery
- Orthopaedic Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Virginia -
Zhengzhou University
Hospital
-
University of Virginia Medical Center
Drug Facts
| NPI NUMBER | 1144243387 | |
| NPPES Provider LastName | CUI | |
| NPPES Provider FirstName | QUANJUN | |
| NPPES Provider ZIPCode | 229032981 | |
| NPPES Provider State | VA | |
| Specialty Description | Orthopedic Surgery | |
| Total Claim Count | 24.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144243387 |
| Last Name Of The Provider | CUI |
| First Name Of The Provider | QUANJUN |
| View All |
Similar Doctors
|
Dr. M Truitt Cooper, MD |
|
Dr. Joylene W. Thomas, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas L. Schildwachter, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark J. Romness, MD |
|
|
Dr. David S. Witmer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David M. Kahler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Megan A. Swanson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory F. Domson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. D Nicole Deal, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Seth R. Yarboro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wojciech L. Czoch, MD |
|
|
Dr. Cody L. Evans, MD |
|
|
Dr. Andrew B. Bridgforth, MD |